Literature DB >> 33506011

Natural Killer T Cells in Various Mouse Models of Hepatitis.

Jun Guan1, Gang Wang1, Qin Yang1, Chao Chen1, Jingwen Deng1, Xinyu Gu1, Haihong Zhu1.   

Abstract

Natural killer T (NKT) cells are a key component of innate immunity. Importantly, a growing body of evidence indicates that NKT cells play an integral role in various acute and chronic liver injuries. NKT cells participate in the progression of an injury through the secretion of cytokines, which promote neutrophil infiltration and enhance Fas ligand (FasL) and granzyme-mediated NKT cytotoxic activity. Therefore, examining the role of NKT cells in hepatic disease is critical for a comprehensive understanding of disease pathogenesis and may provide insight into novel approaches for treatment. For more than a century, mouse models that imitate the physiopathological conditions of human disease have served as a critical tool in biological and medical basic research, including studies of liver disease. Here, we review the role of NKT cells in various mouse models of hepatitis.
Copyright © 2021 Jun Guan et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33506011      PMCID: PMC7810568          DOI: 10.1155/2021/1782765

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  80 in total

Review 1.  Immune mechanisms of Concanavalin A model of autoimmune hepatitis.

Authors:  Hai-Xia Wang; Man Liu; Shun-Yan Weng; Jing-Jing Li; Chao Xie; Hong-Lin He; Wen Guan; Yun-Sheng Yuan; Jin Gao
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

2.  Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration.

Authors:  Stephanie Mathews; Dechun Feng; Igor Maricic; Cynthia Ju; Vipin Kumar; Bin Gao
Journal:  Cell Mol Immunol       Date:  2015-02-09       Impact factor: 11.530

3.  Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism.

Authors:  Bofeng Li; Rui Sun; Haiming Wei; Bin Gao; Zhigang Tian
Journal:  Hepatology       Date:  2006-06       Impact factor: 17.425

4.  Opposing effects of prednisolone treatment on T/NKT cell- and hepatotoxin-mediated hepatitis in mice.

Authors:  Hyo-Jung Kwon; Young-Suk Won; Ogyi Park; Dechun Feng; Bin Gao
Journal:  Hepatology       Date:  2014-01-21       Impact factor: 17.425

Review 5.  New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases.

Authors:  Jessica A Williams; Sharon Manley; Wen-Xing Ding
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

6.  Hyperactivated peripheral invariant natural killer T cells correlate with the progression of HBV-relative liver cirrhosis.

Authors:  Xin Wei; Jingjing Qian; Weifeng Yao; Liling Chen; Huaqin Guan; Yingxiao Chen; Yaosheng Xie; Hong Lu; Zhuo Zhang; Liang Shi; Xiangyang Lin
Journal:  Scand J Immunol       Date:  2019-05-22       Impact factor: 3.487

7.  Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus.

Authors:  Sílvia Vilarinho; Kouetsu Ogasawara; Stephen Nishimura; Lewis L Lanier; Jody L Baron
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-08       Impact factor: 11.205

8.  PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication.

Authors:  X F Wang; Y Lei; M Chen; C B Chen; H Ren; T D Shi
Journal:  J Viral Hepat       Date:  2013-04       Impact factor: 3.728

9.  Natural killer T cells play a necessary role in modulating of immune-mediated liver injury by gut microbiota.

Authors:  Jianing Chen; Yingfeng Wei; Jianqin He; Guangying Cui; Yunan Zhu; Chong Lu; Yulong Ding; Rufeng Xue; Li Bai; Toshimitsu Uede; Lanjuan Li; Hongyan Diao
Journal:  Sci Rep       Date:  2014-12-01       Impact factor: 4.379

Review 10.  NKT cell subsets as key participants in liver physiology and pathology.

Authors:  Keya Bandyopadhyay; Idania Marrero; Vipin Kumar
Journal:  Cell Mol Immunol       Date:  2016-03-14       Impact factor: 11.530

View more
  2 in total

Review 1.  Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review.

Authors:  Kyoko Oura; Asahiro Morishita; Joji Tani; Tsutomu Masaki
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

Review 2.  Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy.

Authors:  Rossella Fasano; Mahdi Abdoli Shadbad; Oronzo Brunetti; Antonella Argentiero; Angela Calabrese; Patrizia Nardulli; Roberto Calbi; Behzad Baradaran; Nicola Silvestris
Journal:  Life (Basel)       Date:  2021-12-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.